Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript May 12, 2024
Cytek Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Thank you for standing by. My name is Liz, and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Paul Goodson, Investor Relations. Please go ahead.
Paul Goodson: Thank you, operator. Earlier today, Cytek Biosciences released financial results for the quarter ended March 31, 2024. If you haven’t received this news release, or if you’d like to be added to the company’s distribution list, please send an…
